000 | 01972 a2200505 4500 | ||
---|---|---|---|
005 | 20250515113545.0 | ||
264 | 0 | _c20080624 | |
008 | 200806s 0 0 eng d | ||
022 | _a1533-2500 | ||
024 | 7 |
_a10.1111/j.1533-2500.2008.00190.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPerrot, Serge | |
245 | 0 | 0 |
_aFibromyalgia: harmonizing science with clinical practice considerations. _h[electronic resource] |
260 |
_bPain practice : the official journal of World Institute of Pain _c |
||
300 |
_a177-89 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aAmines _xtherapeutic use |
650 | 0 | 4 |
_aAnalgesics _xtherapeutic use |
650 | 0 | 4 |
_aCentral Nervous System _xphysiopathology |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aCyclohexanecarboxylic Acids _xtherapeutic use |
650 | 0 | 4 | _aDiagnosis, Differential |
650 | 0 | 4 | _aDisease Management |
650 | 0 | 4 | _aExercise Therapy |
650 | 0 | 4 |
_aFatigue _xetiology |
650 | 0 | 4 |
_aFibromyalgia _xcomplications |
650 | 0 | 4 | _aGabapentin |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperalgesia _xphysiopathology |
650 | 0 | 4 |
_aHypnotics and Sedatives _xtherapeutic use |
650 | 0 | 4 |
_aMyofascial Pain Syndromes _xphysiopathology |
650 | 0 | 4 | _aNeuroimmunomodulation |
650 | 0 | 4 |
_aPain _xphysiopathology |
650 | 0 | 4 | _aPractice Guidelines as Topic |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 |
_aRheumatic Diseases _xphysiopathology |
650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aSleep Disorders, Intrinsic _xetiology |
650 | 0 | 4 |
_agamma-Aminobutyric Acid _xtherapeutic use |
700 | 1 | _aDickenson, Anthony H | |
700 | 1 | _aBennett, Robert M | |
773 | 0 |
_tPain practice : the official journal of World Institute of Pain _gvol. 8 _gno. 3 _gp. 177-89 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1533-2500.2008.00190.x _zAvailable from publisher's website |
999 |
_c17864135 _d17864135 |